| Literature DB >> 32660153 |
Faiez Hentati1,2, Latifa Tounsi1, Djomdi Djomdi3, Guillaume Pierre1, Cédric Delattre1,4, Alina Violeta Ursu1, Imen Fendri5, Slim Abdelkafi2, Philippe Michaud1.
Abstract
Bioactive compounds with diverse chemical structures play a significant role in disease prevention and maintenance of physiological functions. Due to the inEntities:
Keywords: Macroalgae; bioactive agents; biomolecules; polysaccharides; seaweeds
Mesh:
Substances:
Year: 2020 PMID: 32660153 PMCID: PMC7397078 DOI: 10.3390/molecules25143152
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Bioactive compounds from marine seaweeds.
Physicochemical composition of macroalgae.
| Macroalgae | Country | Proteins (%) | Lipids (%) | Carbohydrates (%) | Fibers (%) | References |
|---|---|---|---|---|---|---|
|
| ||||||
|
| Iran | 9.20 | 1.50 | 32.10 | - | Rohani-Ghadikolaei et al. [ |
|
| Tunisia | 9.98 | 2.80 | 39.11 | 57.33 | Hentati et al. [ |
|
| Chile | 10.40 | 0.80 | 70.90 | 71.40 | Ortiz et al. [ |
|
| New Zealand | 9.60 | 1.80 | 66.90 | - | Smith et al. [ |
|
| Portugal | 9.71 | 5.23 | 17.59 | - | Paiva et al. [ |
|
| New Zealand | 6.07 | 2.63 | 62.90 | - | Smith et al. [ |
|
| Iran | 11.83 | 1.79 | - | 11.00 | Tabarsa et al. [ |
|
| Portugal | 14.44 | 1.10 | 45.60 | - | Rodrigues et al. [ |
|
| China | 11.20 | 1.06 | 47.43 | 4.83 | Peng et al. [ |
|
| ||||||
|
| Denmark | 31.10 | 1.10 | 59.10 | - | Parjikolaei et al. [ |
|
| United Kingdom | 31.70 | 0.12 | - | 34.30 | Marsham et al. [ |
|
| Brazil | 19.70 | 0.43 | 63.10 | 5.65 | Marinho-Soriano et al. [ |
|
| Tunisia | 9.81 | 2.76 | 34.54 | 51.68 | Hentati et al. [ |
|
| India | 16.24 | 0.74 | 27.40 | 29.40 | Fayaz et al. [ |
|
| Portugal | 20.79 | 7.53 | 17.61 | - | Paiva et al. [ |
|
| Argentina | 24.61 | 0.25 | - | 48.02 | Cian et al. [ |
|
| ||||||
|
| Borneo | 10.41 | 1.11 | 38.66 | 32.99 | Matanjun et al. [ |
|
| India | 12.44 | 0.32 | 23.86 | - | Kokilam and Vasuki. [ |
|
| Tunisia | 8.46 | 7.87 | - | 54.90 | Yaich et al. [ |
|
| Thailand | 21.06 | 0.75 | 55.77 | 4.84 | Ratana-Arporn and Chirapart [ |
|
| Spain | 17.80 | 0.90 | 42.60 | 11.90 | Taboada et al. [ |
Figure 2Algal polysaccharides classification.
Figure 3Applications of bioactive algal polysaccharides.
Figure 4Structures of fucoidans extracted from brown seaweeds of the Fucales order. (A) Fucoidan of Fucus serratus (and Ascophyllum nodosum) composed of a main chain of (1→3)- and (1→4)-α-l-Fucp with short branches of α-l-Fucp-(1→4)-α-l-Fucp and α-l-Fucp-(1→3)-α-l-Fucp in O-4 of α-(1→3)-l-Fucp and sulfate groups in O-2 and/or O-4 positions. (B) Fucoidan extracted from Fucus evanescens consisting of a main skeleton of (1→3)- and (1→4)-α-l-Fucp highly substituted by sulfate groups at O-2 and/or O-3 positions.
Figure 5Structures of fucoidans from brown seaweeds of the Laminariales order. (A) Fucoidan from Laminaria saccharina composed of a main chain of (1→3)-α-l-Fucp branched at O-2 and O-4 of α-l-Fucp by terminal residues and sulfate groups. (B) Fucoidan obtained from Chorda filum consisting of a (1→3)-α-l-Fucp main backbone highly ramified at O-2 by terminal residues and substituted by sulfate groups at O-2 and/or O-4positions.
Figure 6Structures of (A) laminaribioses and (B) gentiobioses.
Figure 7Structure of alginates. G: guluronate or l-GulpA; M: mannuronate or d-ManpA.
Figure 8Structures of (A) μ-carrageenans, (B) κ-carrageenans, (C) ν-carrageenans, (D) λ-carrageenans and (E) ι-carrageenans.
Figure 9Representation of agarose.
Figure 10Structures of (A) porphyrans and (B) funorans. R: CH3 or SO3−.
Figure 11Structures of ulvans. A: ulvanobiuronate-3-sulfate type A,; B: ulvanobiuronate-3-sulfate type B; U: ulvanobiose-3-sulfate type A; U: ulvanobiose-2,3-disulfate type B.
Figure 12Damage induced by reactive oxygen species (ROS).
Biological properties of algal bioactive polysaccharides.
| Type of PS | Source | Main Monosaccharide | Main Backbone | Biological Properties | References |
|---|---|---|---|---|---|
|
| |||||
| S-fucan |
| Fuc | (1,2)- and (1,3)-α- | Nd | Karmakar et al. [ |
| S-galactofucans |
| Gal | (1,4)- and (1,3)-α- | Anti-thrombotic | Costa et al. [ |
| S-galactofucans |
| Gal | (1,3)-α- | Antiviral | Ponce et al. [ |
| S-fucans |
| Fuc | (1,3)- and (1,4)-α- | Immunomodulatory, anti-inflammatory, anticoagulant, anti-thrombotic | Cumashi et al. [ |
| S-fucans | Fuc | (1,3)- and (1,4)-α- | Immunostimulant, antiviral, antitumor, antiproliferative, antiadhesive | Costa et al. [ | |
| S-galactofucans | Gal | (1,6)-β- | Antitumor | Sokolova et al. [ | |
| S-fucoidan |
| Fuc | (1,3)-α- | Antitumor, antiviral | Ale et al. [ |
| S-fucans |
| Fuc | (1,3)- or (1,6)-, and (1,4)-α- | Anti-proliferative, antitumor, anticoagulant, antioxidant, antithrombotic, anti-inflammatory | Ermakova et al. [ |
| S-galactofucan |
| Gal | (1,3)- and (1,4)-α- | Anti-lipidaemic, antiviral, antitumor, immunomodulator, antioxidant neuroprotective | Fedorov et al. [ |
|
| |||||
| S-λ-carrageenan |
| Gal | (1,3)-α- | Antiviral, anticoagulant, antithrombotic | Albuquerque et al. [ |
| S-κ-carrageenan |
| Gal | (1,3)-α- | Anticoagulant, anti-thrombotic | Prajapati et al. [ |
| S-carrageenans |
| Gal | (1,3)-α- | Antiviral | Prajapati et al. [ |
| Carrageenan |
| Gal | (1,3)-α- | Anticancer | Souza et al. [ |
| LMW-carrageenans |
| Gal | (1,3)-α- | Antitumor | Lins et al. [ |
|
| |||||
| S-arabinogalactans | Gal | (1,3)-β- | Anticoagulant, antithrombotic, antiviral | Takano et al. [ | |
| S-ulvans |
| Rha | [→4)-β- | Antioxidant, anti-proliferative, hypocholesterolaemic | Usui et al. [ |
| S-PS |
| Rha | β- | Immunostimulatory | Lahaye and Robic [ |
| S-rhamnans |
| Rha | (1,3)-α- | Antiviral, anticoagulant | Lee et al. [ |
PS: Polysaccharides; S-PS: Sulfated polysaccharides; LMW: Low Molecular Weight; Nd: Not determined.
Figure 13Potentials of marine-derived algae polysaccharide (SP)-based engineered cues to induce cell death of tumor cells (apoptosis).
Figure 14Signaling pathways involved in natural killer cell (NK cells) activation by bioactive algal polysaccharides.
Figure 15Signaling pathways involved in macrophage activation by algal-sulfated polysaccharides.